CD8A and neoplasm: Patients with high-risk scores and poor prognoses displayed decreased levels of beneficial immune cells, such as CD8+ T cells, CD4+ T cells, M1 macrophages, and NK cells, whereas cells that support tumor progression, such as endothelial cells, tumor-associated fibroblasts, and stromal infiltration, were elevated.